AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Neurocrine BiosciencesModernaQiagenBIO-TECHNEargenx
SymbolNASDAQ:NBIXNASDAQ:MRNANYSE:QGENNASDAQ:TECHNASDAQ:ARGX
Price Information
Current Price$118.95$60.00$44.08$259.45$230.57
52 Week RangeBuyBuyHoldBuyBuy
Beat the Market™ Rank
Overall Score1.81.41.22.11.2
Analysis Score2.32.42.12.32.4
Community Score3.62.92.22.42.5
Dividend Score0.00.00.03.30.0
Ownership Score1.01.01.01.01.0
Earnings & Valuation Score1.90.60.61.30.0
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$117.27$65.70$37.00$243.22$220.40
% Upside from Price Target-1.42% downside9.50% upside-16.06% downside-6.25% downside-4.41% downside
Trade Information
Market Cap$11.36 billion$23.08 billion$9.95 billion$10.02 billion$9.86 billion
Beta1.320.680.321.151.23
Average Volume942,60932,001,9201,011,522324,465247,599
Sales & Book Value
Annual Revenue$788.10 million$60.21 million$1.53 billion$714.01 million$78.17 million
Price / Sales14.02369.936.5813.89126.21
Cashflow$0.66 per shareN/A$2.68 per share$5.91 per shareN/A
Price / Cash180.97N/A16.4443.90N/A
Book Value$6.92 per share$3.49 per share$11.14 per share$30.78 per share$30.88 per share
Price / Book17.1917.193.968.437.47
Profitability
Net Income$37.01 million$-514,020,000.00$-41,460,000.00$96.07 million$-182,520,000.00
EPS$0.39($1.55)$1.43$3.80($4.73)
Trailing P/E Ratio64.65N/AN/A54.85N/A
Forward P/E Ratio25.31N/A25.3358.83N/A
P/E GrowthN/AN/A$2.10$12.41N/A
Net Margins19.90%-963.84%-2.01%24.77%N/A
Return on Equity (ROE)37.53%-37.49%13.80%13.04%N/A
Return on Assets (ROA)18.29%-29.24%6.68%8.13%N/A
Dividend
Annual PayoutN/AN/AN/A$1.28N/A
Dividend YieldN/AN/AN/A0.49%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A33.68%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.71%N/A0.56%0.37%N/A
Current Ratio6.90%9.29%1.58%4.69%8.58%
Quick Ratio6.75%9.29%1.41%3.74%8.58%
Ownership Information
Institutional Ownership Percentage96.75%52.01%60.20%95.68%54.53%
Insider Ownership Percentage4.30%29.20%9.00%4.20%N/A
Miscellaneous
Employees5857605,0962,250103
Shares Outstanding92.86 million371.22 million227.75 million38.22 million42.79 million
Next Earnings Date8/3/2020 (Estimated)8/5/2020 (Estimated)7/22/2020 (Estimated)8/4/2020 (Estimated)N/A
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.